
Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol TÂ Extension Study)
Glassman, Adam R., Wells, John A., Josic, Kristin, Maguire, Maureen G., Antoszyk, Andrew N., Baker, Carl, Beaulieu, Wesley T., Elman, Michael J., Jampol, Lee M., Sun, Jennifer K.Journal:
Ophthalmology
DOI:
10.1016/j.ophtha.2020.03.021
Date:
March, 2020
Fichier:
PDF, 800 KB
2020